7 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Progression: • Upper lobe ... characteristic features Clinical ... Diagnosis: Latent ... #TB #Diagnosis ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Progression: • Upper lobe ... characteristic features Clinical ... Diagnosis: Latent ... #TB #Diagnosis ... #Management #Treatment
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
- Diagnosis and ... extrapulmonary cases Clinical ... symptoms of active pulmonary ... for concomitant pulmonary ... #TB #Diagnosis
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
LATENT TB • ... LTBI is diagnosed ... result with no clinical ... IGRA/QuantiFERON-TB ... used to exclude pulmonary
Blastomycosis (Blastomyces): Gilchrist’s disease, Chicago disease - Summary Sheet
 • Morphology
 • Geography, Reservoir and Mode
inoculation • Clinical ... presentation of TB ... with an upper lobe ... • Management ... #management #summary
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
Mycobacterium tuberculosis ... of right middle lobe ... Kansasii: • Mimics TB ... Disease: Clinical ... Lung Disease: • Clinical
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... and molecular diagnostic ... HIV-infected persons with clinical ... Mycobacterium #Tuberculosis ... #Treatment #management